Prognostic impact of mutation profiling in patients with stage II and III colon cancer - Wikidata - awgldk - TriplyDB

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

http://www.wikidata.org/entity/Q36796320

about

Colorectal cancer in cases of multiple primary cancers: Clinical features of 59 cases and point mutation analyses.FBXW7 missense mutation: a novel negative prognostic factor in metastatic colorectal adenocarcinoma.Dual specificity phosphatase 5 is a novel prognostic indicator for patients with advanced colorectal cancer.Coexistence of MSI with KRAS mutation is associated with worse prognosis in colorectal cancer Current and future biomarkers in the treatment of colorectal cancer.Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients.Integrated analysis of colorectal cancer microRNA datasets: identification of microRNAs associated with tumor development.Combined assessment of the TNM stage and BRAF mutational status at diagnosis in sporadic colorectal cancer patients.Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.Comprehensive Validation of Snapback Primer-Based Melting Curve Analysis to Detect Nucleotide Variation in the Codon 12 and 13 of KRAS Gene

P2860

Q33751189-9F759B6E-3547-4ACB-9BD5-22A1298B035D Q33889158-35D54B56-F5B8-4BD6-94FD-F5CE4D13F273 Q37382545-34058307-EDF8-4CC3-854E-7633CE8FD37C Q37608405-7A54FF08-DFDC-441E-BD3B-814D3E21C9B2 Q38787244-56A25653-A91E-492B-96E2-672EA2BBDA21 Q52582055-9B6F8B26-5CB6-4780-9EC0-7B0D41698C01 Q55000717-F2EBDEF8-B741-46A5-8440-14AB13BBB401 Q55154129-A70290E4-47B7-49E6-852F-D31D10B387E8 Q55408333-4FCAE710-89B2-4E82-85BB-1B2D491C73B2 Q55411157-3C5DA6C7-4346-437D-B498-7165CD71C640 Q58575063-13FFFEB8-7D7D-4230-BF3C-1E21CAD1456F

P2860

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

http://www.wikidata.org/entity/Q36796320

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

@en

type

label

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

@en

prefLabel

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

@en

P1433

Q36796320-9BB8EA44-4C70-4417-868E-A66E727AD592

P1476

Q36796320-6059AE00-2D08-4586-8E70-6867EEB91DDB

P2093

Q36796320-0BC4A17E-C025-46AA-AE29-261AD6F0DF6F

Q36796320-35A7A97F-920A-47C5-87AF-0451279C2DC0

Q36796320-53C0755E-6133-41F6-A305-F637FA3CC822

Q36796320-5A0D4C1A-0B13-4188-AE09-99C8AABE5A40

Q36796320-7B849902-42E5-4A6E-A318-2C909D8FF81B

Q36796320-A4CE990C-F99A-4F2E-8D6E-5EED6E9D4B41

Q36796320-E12D154A-FA01-408F-AA3F-56CEAC50BA96

P2860

Q36796320-0636BC5E-4ED6-4E0F-9830-D63A8E5E403D

Q36796320-1305CAF9-381F-4590-9907-9F7CDB5456A0

Q36796320-1A5BB8D1-92B5-48A3-AF2D-60D9B8C72654

Q36796320-1ECFCDC7-A196-493E-AE46-AAC6DD79C0A4

Q36796320-2B7F4B03-7270-4D17-92A9-00B5C56A32E4

Q36796320-36F49828-B66C-41AB-8A3F-3829AF2D5AD2

Q36796320-37FCFEA0-EB32-4367-BFAF-F98798F1198F

Q36796320-4798825D-CF69-4020-A0D8-203A73D70B4A

Q36796320-539B2BDD-C3A9-4FED-9CBB-52B12FED39DC

Q36796320-572D1322-3BC5-4965-AF08-D96E042EDB8F

P2888

Q36796320-1ADB70B0-05A5-4FB0-A78A-12A809C09E9C

P304

Q36796320-681C04B7-8A92-4814-AC42-682C1BB1F318

P31

Q36796320-C6CA0A45-5FA7-47E1-90E2-AA020E3E436B

P356

Q36796320-E4EE05BF-C38A-4BD5-96CC-7FE0FA00945A

P407

Q36796320-F8323D16-FDF1-439B-9F5B-F0230CC62CBB

P478

Q36796320-BAD146FD-DCD5-40F2-A9AF-7C65332E052B

P577

Q36796320-7F36AEBD-3FD0-4C01-A4C2-63039BAE6C8A

P698

Q36796320-9FEC681B-8680-4CA5-813F-4E371C8A401E

P932

Q36796320-D6F35FB4-219C-4037-950B-99F70841EFC6

P356

P1433

Scientific Reports

P1476

Prognostic impact of mutation profiling in patients with stage II and III colon cancer

@en

P2093

Hongying Yang

http://www.w3.org/2001/XMLSchema#string

Jianfei Wang

http://www.w3.org/2001/XMLSchema#string

Shih-Hsin Lu

http://www.w3.org/2001/XMLSchema#string

Shuai Wang

http://www.w3.org/2001/XMLSchema#string

Xiaohong Han

http://www.w3.org/2001/XMLSchema#string

Yinchen Shen

http://www.w3.org/2001/XMLSchema#string

Yuankai Shi

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Molecular origins of cancer: Molecular basis of colorectal cancer

The PI3K pathway as drug target in human cancer

KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803

Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis.

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

Mutations of the BRAF gene in human cancer

Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a meta-analysis

Extended RAS testing in metastatic colorectal cancer-Refining the predictive molecular biomarkers

Targeting RAS signalling pathways in cancer therapy

P2888

P304

24310

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SREP24310

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2016-04-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27074743

http://www.w3.org/2001/XMLSchema#string

P932

4830995

http://www.w3.org/2001/XMLSchema#string